Your browser doesn't support javascript.
Enhanced High Mutation Rate and Natural Selection to Produce Attenuated Viral Vaccine with CRISPR Toolkit in RNA Viruses especially SARS-CoV-2.
Jamehdor, Saleh; Naserian, Sina; Teimoori, Ali.
  • Jamehdor S; Department of Virology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. Electronic address: Salehjamehdor@ut.ac.ir.
  • Naserian S; Inserm UMR-S-MD 1197, Hôpital Paul Brousse, Villejuif, France; Paris-Saclay University, Villejuif, France; CellMedEx, Saint Maur des Fossés, France. Electronic address: sina.naserian@inserm.fr.
  • Teimoori A; Department of Virology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. Electronic address: teimooriali1982@gmail.com.
Infect Genet Evol ; 97: 105188, 2022 01.
Article in English | MEDLINE | ID: covidwho-1568934
ABSTRACT
The best and most effective way to combat pandemics is to use effective vaccines and live attenuated vaccines are among the most effective vaccines. However, one of the major problems is the length of time it takes to get the attenuated vaccines. Today, the CRISPR toolkit (Clustered Regularly Inerspaced Short Palindromic Repeats) has made it possible to make changes with high efficiency and speed. Using this toolkit to make point mutations on the RNA virus's genome in a coculture of permissive and nonpermissive cells and under controlled conditions can accelerate changes in the genome and accelerate natural selection to obtain live attenuated vaccines.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Proteins / Mutation Rate / CRISPR-Cas Systems / Gene Editing / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies Topics: Vaccines Limits: Humans Language: English Journal: Infect Genet Evol Journal subject: Biology / Communicable Diseases / Genetics Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Proteins / Mutation Rate / CRISPR-Cas Systems / Gene Editing / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies Topics: Vaccines Limits: Humans Language: English Journal: Infect Genet Evol Journal subject: Biology / Communicable Diseases / Genetics Year: 2022 Document Type: Article